NAT-based detection reduces risks of malaria in blood donors, highlighting the need for standardized screening and molecular testing.
Individuals testing positive for Plasmodium spp. by NAT PLUS assay may progress to clinical malaria post-donation, posing risks to both donor health and transfusion safety. The frequent absence of information on malaria exposure during clinical screening highlights the need for standardized protocols and molecular testing to improve early identification of at-risk donors in endemic regions.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: